(Recasts with context, details, share price indication) ZURICH, Sept 8 (Reuters) – Swiss drugmaker Novartis on Tuesday said its experimental drug for a muscle wasting disorder failed in a late-stage
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Gauff embraces pressure as Blockx overcomes injury scare
VIDEO SHOWS: US OPEN DAY NINE POST MATCH PRESS CONFERENCE SOUNDBITES FROM COCO GAUFF AND…
Sibanye weighs cuts at ageing platinum shaft, over 1,000 jobs at risk
Sept 8 (Reuters) - Sibanye Stillwater said on Tuesday it plans to restructure the Kwezi…
Australia targets social media algorithms with new user-choice rules
By Renju Jose SYDNEY, Sept 8 (Reuters) - Australia on Tuesday proposed giving social media…
